Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cross-presentation is one of the main features of dendritic cells (DCs), which is critically important for the development of spontaneous and therapy-inducible antitumor immune responses. Patients, at early stages of cancer, have normal presence of DCs. However, the difficulties in the development of antitumor responses in patients with low tumor burden raised the question of the mechanisms of DC dysfunction. In this study, we found that, in differentiated DCs, tumor-derived factors blocked the cross-presentation of exogenous Ags without inhibiting the Ag presentation of endogenous protein or peptides. This effect was caused by intracellular accumulation of different types of oxidized neutral lipids: triglycerides, cholesterol esters, and fatty acids. In contrast, the accumulation of nonoxidized lipids did not affect cross-presentation. Oxidized lipids blocked cross-presentation by reducing the expression of peptide-MHC class I complexes on the cell surface. Thus, this study suggests the novel role of oxidized lipids in the regulation of cross-presentation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“hypoxic tumors have been shown to exhibit decreased MHC-I expression in tumor cells and DCs (Ramakrishnan et al., 2014).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Ramakrishnan et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 1×
“generation of cells with immune-suppressive activity, including regulatory DCs and myeloid-derived suppressor cells (4).”
BackgroundSelf-citationBatf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081
Lipid Droplets and Cellular Lipid Metabolism
Walther, T. C., & Farese, R. V. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061009-102430 · Cited by 1,661 · cited 1×
“The presence and size of LBs is defined by the accumulation of FA precursors and their esterification into TAGs and CEs, the major constituents of the hydrophobic core of LBs (26).”
BackgroundCross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637 · cited 2×
“The endogenous pathway of presentation invariably depends on proteasomes, whereas the pathway of cross-presentation (cytosolic or vacuolar) depends on the type of Ag and the mechanism of its uptake (12, 35).”
BackgroundMechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
Self-citationBevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956 · cited 1×
“generate peptide T cell epitopes that are presented by MHC class I (MHC-I) molecules (9, 10).”
BackgroundLipid accumulation and dendritic cell dysfunction in cancer
Herber, D. L., Cao, W., Nefedova, Y., Novitskiy, S. V., Nagaraj, S., Tyurin, V. A., Corzo, A., Cho, H.-I., Celis, E., Lennox, B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2172 · Cited by 735
Self-citationEndoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages
Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J. M., & Desjardins, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00797-3 · Cited by 683 · cited 1×
“In addition to recycling MHC-I, transport of MHC-I, from ER to the endocytic compartment, has also been demonstrated (49, 50).”
BackgroundMechanisms and Consequences of Dendritic Cell Migration
Alvarez, D., Vollmann, E. H., & von Andrian, U. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.006 · Cited by 525
Cited by
Items 201–300 of 328
Mitochondrial lipid metabolism in tumor immunosurveillance and evasion
Plata-Gómez, A. B., Chen, W., Ho, P., & Ling, G. S. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.08.005 · Cited by 17
The new era of lung cancer therapy: Combining immunotherapy with ferroptosis
Li, Y., Tuerxun, H., Zhao, Y., Liu, X., Li, X., Wen, S., & Zhao, Y. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104359 · Cited by 17
Tognarelli, E. I., Retamal-Díaz, A. R., Farías, M. A., Duarte, L. F., Palomino, T. F., Ibañez, F. J., Riedel, C. A., Kalergis, A. M., Bueno, S. M., & González, P. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.764861 · Cited by 17
“Although IRE1a activation is frequently considered a positive process for the cell for exiting ER stress, recently, it was reported that constitutive activation of XBP1 in tumor-associated DCs inhibits the capacity of these cells to activate anti-tumor T cells (32, 33).”
BackgroundEtiology of lipid-laden macrophages in the lung
Stevenson, E. R., Smith, L. C., Wilkinson, M. L., Lee, S. J., & Gow, A. J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110719 · Cited by 16
Harnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
Zeng, J., Zhang, X., Lin, Z., Zhang, Y., Yang, J., Dou, P., & Liu, T. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00498-3 · Cited by 16
Research progress on the role of cholesterol in hepatocellular carcinoma
Li, P., Yan, Q., Chen, Z., Hu, Y., Sun, Y., Yu, M., Wu, Y., Yao, Y., Tao, L., Chen, F., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175410 · Cited by 16
Chen, H., Sun, Y., Yang, Z., Yin, S., Li, Y., Tang, M., Zhu, J.-P., & Zhang, F. (2021) · Oncology Reports · doi:10.3892/or.2021.7946 · Cited by 15
“Herber et al (102) evaluated lipid accumulation in tumor‐infiltrating DCs that would hinder antigen presentation and major histocompatibility complex II expression, and inhibition of acetyl‐CoA carboxylase 1 reversed the effects of lipids, suggesting that this process involved the fatty acid biosynthesis pathway (102,…”
BackgroundPeng, Y., Cui, D., Li, W., Ding, M., Shi, Y., Wang, T., Shi, D., Chi, J., Li, P., & Zhai, B. (2021) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1851_20 · Cited by 15
Chen, Y., Guo, L., Zhou, Z., An, R., & Wang, J. (2022) · BMC Genomics · doi:10.1186/s12864-022-08475-y · Cited by 15
“DCs were found to accumulate large amounts of lipids and polyunsaturated fatty acids in tumor patients, which led to a decline in their ability to present antigens and unable to fully stimulate activated CD8+T cell [46, 47].”
BackgroundDendritic cells metabolism: a strategic path to improve antitumoral DC vaccination
Currivan, E., Finlay, D. K., & Moreira, D. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac048 · Cited by 15
Starodubtseva, N. L., Tokareva, A., Родионов, В. В., Brzhozovskiy, A. G., Bugrova, A. E., Chagovets, V., Кометова, В. В., Kukaev, E., Soares, N. C., Kovalev, G. I., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11071786 · Cited by 15
From damage signals to immune modulators: oxidized lipids in immunometabolic inflammation
Srivastava, N., & Wan, X. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100990 · Cited by 14
“In tumor-associated DCs, oxidized lipids disrupt the trafficking of peptide-major histocompatibility complex (MHC) class I complexes to the cell surface, limiting CD8 + T-cell activation (98, 99).”
Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological Diseases
Васильевич, К. В., Alshevskaya, A., & Sennikov, S. V. (2024) · Biomedicines · doi:10.3390/biomedicines12030699 · Cited by 14
“These lipid particles inhibit the migration of the peptide–MHC I complex to the surface of dendritic cells and impair the cross-presentation potential of T cells, blocking their activity [31,32].”
BackgroundYing, S., Liu, H., Zhang, Y., & Mei, Y. (2025) · Vaccines · doi:10.3390/vaccines13050496 · Cited by 14
“These vesicles form covalent bonds with HSP70, disrupting the transmembrane translocation of antigenic peptide-major histocompatibility complex I (pMHC-I) complexes, thereby impairing DC-mediated antigen cross-presentation [48,49].”
Mittal, R., Goldmann, R., Mittal, M., Chaudhary, N., Ravindra, V., & Hirani, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1744422 · Cited by 14
“These alterations may impair the processing of conventional peptide antigens while enhancing the presentation of lipid antigens through CD1 molecules (133, 142 – 144).”
Li, N., Song, X., Peng, X., Li, M., Zhu, M., Xiao, R., Wang, L., Ling, L., Zhao, Y. J., Wang, T., et al. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.04.010 · Cited by 15
Fatty acid metabolism and radiation-induced anti-tumor immunity
Martino, M. D., Daviaud, C., Hajjar, E., & Vanpouille‐Box, C. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.01.003 · Cited by 14
Fatty Acid Mediators in the Tumor Microenvironment
Khadge, S., Sharp, J. G., Thiele, G. M., McGuire, T. R., & Talmadge, J. E. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_8 · Cited by 14
Decoding immunometabolism with next-generation tools: lessons from dendritic cells and T cells
Wang, Y., Wang, L., & Ho, P. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00569-z · Cited by 13
Acevedo, N., Lozano, A. M., Zakzuk, J., Llinás-Caballero, K., Brodin, D., Nejsum, P. L., Williams, A. R., & Caraballo, L. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328401 · Cited by 13
“For example, accumulation of intracellular oxidized lipids (cholesterol, triglycerides, and fatty acids) induced by tumor-derived factors impacts antigen presentation in human moDCs and mouse DCs (59, 60).”
BackgroundXue, J., Zhang, L., Zhang, K., Wu, Y., Zhou, K., & Lü, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1697056 · Cited by 12
Lipid Metabolism and Tumor Antigen Presentation
Qin, H., & Chen, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_11 · Cited by 12
Targeting fatty acid metabolism for cancer therapy
Zhang, L., Yao, Y., & Liu, S. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.09.011 · Cited by 12
Scalambra, L., Ruzzi, F., Pittino, O. M., Semprini, M. S., Cappello, C., Angelicola, S., Palladini, A., Nanni, P., Goksøyr, L., Fougeroux, C. E., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06126-w · Cited by 12
Farías, M. A., Cancino, F. A., Navarro, A. J., Duarte, L. F., Soto, A. A., Tognarelli, E. I., Ramm, M. J., Alarcón-Zapata, B., Cordero, J., Martin, S. S., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112441 · Cited by 11
Liang, Z., Schmidtke, M. W., & Greenberg, M. L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.915301 · Cited by 11
Immuno-onco-metabolism and Therapeutic Resistance
Mir, M. A., Aisha, S., Nisar, S., Qayoom, H., & Mehraj, U. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_3 · Cited by 11
Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging
Penna, F., Rubini, G., & Costelli, P. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101318 · Cited by 11
“Acquisition of the latter is the final step of a chain of events starting in the bone marrow (the so called ‘immunometabolic reprogramming ’ ) and ending in the tumor microenvironment (Cao et al., 2014).”
Glycolysis in the tumor microenvironment shapes dendritic cell function and antitumor immunity
Zhang, B., Zhao, L., Li, H., Wang, N., Wang, X., Shang, L., Sun, B., & Kong, F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1744671 · Cited by 11
Suarez‐Carmona, M., Hampel, M., Zhang, X.-W., Pöchmann, A., Grauling-Halama, S., Valous, N. A., Charoentong, P., Ferber, D., Wißfeld, J., Höflich, A., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02594-8 · Cited by 10
Workshop Report: Modulation of Antitumor Immune Responses by Dietary and Microbial Metabolites
Kumar, A., Smith, C. K., Jobin, C., Trinchieri, G., Howcroft, T. K., Seifried, H. E., Espey, M. G., Flores, R., Kim, Y. S., & Daschner, P. J. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx040 · Cited by 10
Jiang, R., He, S., Gong, H., Wang, Y., Wei, W., Chen, J., Hu, J., Ye, C., LiuHuang, S., Jin, S., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8441676 · Cited by 10
“A few important steps that take place during the interaction between the immune and ferroptosis malignant cells are observed to be phagocytosis and migration, maturation, antigen-processing, and the cross-presentation by DCs [39, 40].”
RetractedImmunometabolism of Innate Immune Cells in Gastrointestinal Cancer
Siemińska, I., & Lenart, M. (2025) · Cancers · doi:10.3390/cancers17091467 · Cited by 9
“Additionally, oxidase lipid storage was observed in DC which impairs their ability to cross-present tumor antigens in mouse CRC cell lines [106].”
Innovative gene engineering and drug delivery systems for dendritic cells in cancer immunotherapy
Prakash, M., Cortez, C. D., Jayaraman, A., Hsu, S.-Y., Huang, Y., Yeh, C.-Y., & Lee, Y. L. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01191-1 · Cited by 10
“This triggers ER stress response and activates the unfolded protein response sensor, inositol-requiring enzyme 1 α (IRE1α), leading to the transcriptional activation of XBP1 [97].”
Yu, C., Li, X., Qian, X., Zhang, H., Li, X., Wang, B., Li, M., Liu, Z., Du, W., Chen, S., et al. (2026) · Oncogenesis · doi:10.1038/s41389-026-00600-w · Cited by 9
“Tumor cells with lipid peroxidation lack immunogenicity and impair the cross-presentation and anti-tumor ability of DCs [58].”
Mbah, N. E., Sutton, D., Hong, H. S., Singhal, R., Menjivar, R. E., Perricone, M. D., Giza, H., Sajjakulnukit, P., Myers, A. L., Nwosu, Z. C., et al. (2026) · Cancer & Metabolism · doi:10.1186/s40170-026-00428-3 · Cited by 9
NINJ1 in Cell Death and Ferroptosis: Implications for Tumor Invasion and Metastasis
Chen, S.-Y., Shyu, I., & Chi, J. (2025) · Cancers · doi:10.3390/cancers17050800 · Cited by 8
“For instance, ferroptotic tumor cells release immuno-suppressive factors such as prostaglandin E2 (PGE2) and oxidized lipids, which impair dendritic cell function, antigen presentation, and antitumor immune responses [124–127].”
Tumor immune microenvironment modulation by cholesterol in hepatocellular carcinoma
Escobedo‐Calvario, A., Chávez-Rodríguez, L., Nieves, A. S., Souza-Arroyo, V., Miranda-Labra, R. U., Gómez-Quiroz, L. E., & Gutiérrez‐Ruíz, M. C. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00003 · Cited by 8
“DC have opposite effects with lipids, mainly oxidized lipid forms, inhibiting antigen cross-presentation and peptide MHC class I complexes, and reducing anti-tumor surveillance in different tumor models [67].”
BackgroundWang, W., Guo, M., Bai, Z., Bai, W., Chen, W., Su, Y., & Wu, J. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2708243 · Cited by 8
“Reactive metabolic byproducts induced by the TME, like 4-hydroxynonenal (4-HNE), promote the development of ER stress responses in infiltrating tumorassociated dendritic cells (tDCs) [22].”
BackgroundPPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications
Соболев, В. В., Tchepourina, E., Соболева, А. Г., Denisova, E., Korsunskaya, I. M., & Mezentsev, A. V. (2025) · Cells · doi:10.3390/cells14070534 · Cited by 8
“This leads to downregulation of major histocompatibility complex class I (MHCI) molecules and a reduction in their representation on the cell surface [293].”
The impact of obesity and lipids on cancer: Insights into mechanisms and potential interventions
Romero, M., Lian, Y., Piquer, A., Borràs-Ferré, N., Zorzano, A., & Ivanova, S. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.07.006 · Cited by 8
Myeloid Immune Cells CARrying a New Weapon Against Cancer
Ramos, R. N., Couto, S. C. F., de Oliveira, T. G. M., Klinger, P. H. D. S., Braga, T. T., Rego, E. M., Barbuto, J. A. M., & Rocha, V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.784421 · Cited by 8
“The accumulation of some metabolites such as fatty acid and lactic acid also impair the antigen processing and presentation as well as the production of pro-inflammatory cytokines by DC (Herber et al., 2010; Cao et al., 2014; Caronni et al., 2018).”
BackgroundEmerging dual role of ferroptosis in lung cancer (Review)
Wu, A., Ni, Y., Zhou, Y. L., & Shi, J. (2025) · Oncology Reports · doi:10.3892/or.2025.8974 · Cited by 6
“Notably, oxidized phosphatidylcholine activates Nrf2 and promotes the differen‑ tiation of T helper 17 cells, inhibiting DC maturation (87,88).”
Zhan, Q., Ni, H., Zhou, M., Mao, X., Ouyang, Y., Shi, T., & Li, R. (2025) · Medical Review · doi:10.1515/mr-2025-0035 · Cited by 6
Unpacking the lipid–immune axis in health and disease
Raeisi, M., Yousefi, M., Motavalli, R., Hassanzadeh, A., Seddighi, N., Mehri, M., Ebrahimi, S., Mehdizadeh, A., & Abbasi, K. (2026) · Immunology and Cell Biology · doi:10.1111/imcb.70076 · Cited by 6
“53,54 Further, increased lipid proportions in DCs are associated with reduced T-cell stimulatory capacity, which may facilitate tumor immune evasion.”
Metal‐dependent regulated cell death: Molecular architecture and translational frontiers
Hu, H., Chen, Z., Li, Y., Peng, J., Cao, J., Zhou, H., Wang, M., Du, Y., Wu, H., Zhao, H., et al. (2026) · iMeta · doi:10.1002/imt2.70141 · Cited by 6
Tang, X., Zhao, Y., Gu, Y., Chen, M., Dai, J., Jiang, Y., Lan, Y., Cui, Y., Fu, L., Li, X., et al. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.01.011 · Cited by 5
Mitochondrial complex I activity promotes antigen cross-presentation in dendritic cells
Khouili, S. C., Priego, E., Heras‐Murillo, I., Dunphy, G., Mastrangelo, A., Martínez-Cano, S., Nuñez, V., Rodrigo-Tapias, M., García, A. B., Garaude, J., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aef0098 · Cited by 5
Newnes, H. V., Armitage, J. D., Audsley, K. M., Bosco, A., & Waithman, J. C. (2021) · Cancers · doi:10.3390/cancers13235911 · Cited by 5
“Tumourderived lactic acid [69] and the accumulation of lipids [70,71] have both been shown to cause DC dysfunction and impaired anti-cancer responses.”
BackgroundCurrent Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment
Farhangnia, P., Ghomi, S. M., Mollazadehghomi, S., & Delbandi, A. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2023_163 · Cited by 5
The coming decade in ferroptosis research: Five riddles
Levkina, A. (2025) · Ferroptosis and Oxidative Stress · doi:10.70401/fos.2026.0012 · Cited by 4
Yang, L., Zhang, C., Zhang, Z., Yao, S., Shen, J., Zhang, Z., Xiao, Z., Wang, S., & Wu, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07887-8 · Cited by 4
“However, excessive lipid oxidation or abnormal lipid droplet (LD) accumulation can disrupt the formation and stability of MHC I complexes, ultimately impairing the antigen-presenting function of DCs [159, 160].”
Immunoferroptosis: ferroptosis meets tumor immunity and immunotherapy
Chen, X. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.03.008 · Cited by 4
Álvarez-Álvarez, A., Fernández, M. G., & Ortiz-Muñoz, G. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.05.001 · Cited by 4
[Cholesterol Metabolism and Tumor Immunity].
Luo, N., Shi, R., Dai, R., & Miao, H. (2022) · PubMed Central · doi:10.12182/20220360202 · Cited by 4
Nunes, P. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0373-3 · Cited by 4
“bearing exogenous but not endogenous peptides [5].”
The role of lipid metabolic interactions in reshaping the tumor microenvironment
Yang, R., Liu, S., Bi, Y., Jin, R., Ye, Z., Cai, X., Bode, A. M., Liu, W., & Luo, X. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025166 · Cited by 3
“Cross - presentation is directly regulated by oxidized lipid accumulation in DCs. Lipid oxide can block cross - presentation by reducing the expression of the peptide - MHC class I complex on cell surfaces [99].”
Targeting Ferroptosis to Overcome Radioresistance and Enhance Immunotherapy in Colorectal Cancer
Tehrani, S. S., Olson, S. I., Kundu, K., Ferrandon, S., & Kalady, M. F. (2026) · Cells · doi:10.3390/cells15110993 · Cited by 3
“Macrophage-derived reactive oxygen species and inflammatory cytokines increase oxidative stress in adjacent tumor cells and amplify lipid-peroxide accumulation [118].”
Foglia, B., Nurcis, J., Signorini, M., & Cannito, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1823145 · Cited by 4
“Tumor-derived metabolites further reshape mitochondrial metabolism in TAMs.”
InfluentialUnderstanding the Crosstalk Between Epigenetics and Immunometabolism to Combat Cancer
Seth, A., & Kar, S. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_18 · Cited by 3
Hung, Y.-P., Chen, C.-L., Tseng, P., Satria, R. D., Chen, M.-C., & Lin, C. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.02.006 · Cited by 3
Lipids as regulators of inflammation and tissue regeneration
Tyurina, Y. Y., Tyurin, V. A., Kapralov, A. A., Hussey, G. S., Timashev, P. S., Shvedova, A. A., Badylak, S. F., & Kagan, V. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821440-4.00005-0 · Cited by 2
Self-citationImmunometabolism in cancer: A journey into innate and adaptive cells
Sant’Ana, A. N., Dias, C. K., Silva, S. K. E., & Figueiró, F. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2401353 · Cited by 2
Huber, D., Yerneni, S. G. K., Hofmann, L., Ludwig, S., Hoffmann, T. K., Wollenberg, B., WHITESIDE, T., & Theodoraki, M. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1680167 · Cited by 2
Copper potentiates PUFA-mediated antitumor activity by activating Lipophagy
He, X., Yang, Q., Lin, X., Chen, Z., Ren, K., Yang, J., An, X., Yang, S., Yang, L., Xue, Q., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112454 · Cited by 2
Ma, Q., Chen, B., Li, T., Lu, Y., & Li, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02631-8 · Cited by 2
Ferroptosis surveillance: Insights from in vivo contexts
Vaughan, A. J., Palma, M., Ubellacker, J. M., & Papagiannakopoulos, T. Y. (2025) · Ferroptosis and Oxidative Stress · doi:10.70401/fos.2026.0021 · Cited by 2
“Different groups disagree on the effect of ferroptotic death on immune cell activation [76–78] .”
Choudhury, P. R., Chakravarti, M., Bera, S., Arora, P., Sultana, J., Khan, M. A., Biradar, R., Guha, A., Dhar, S., Ghosh, I., et al. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201250 · Cited by 2
“21 Our cumulative experimental analysis established that atorvastatin pre-exposure substantially reversed the detrimental effects of cholesterol-derived 27HC on cDC1s.”
Perspective Chapter: Dendritic Cells in the Tumor Microenvironment
Jin, D., Font, L. F., & Flores, C. T. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108586 · Cited by 2
Redox Pioneer: Professor Valerian Kagan
Bayır, H., Maguire, J. J., & Cadenas, E. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0079 · Cited by 2
Topouza, D. G., Choi, J., Nesdoly, S., Tarnouskaya, A., Nicol, C. J. B., & Duan, Q. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.09.289868 · Cited by 2
DNGR-1 Acts as a cDC1-specific Checkpoint during Flt3L-based Cancer Immunotherapy
Rodríguez, C., & Javier, F. (2020) · Hispana · Cited by 2
Liu, X., Qi, Y., Hu, F., Shu, K., & Lei, T. (2022) · Oncology and Translational Medicine · doi:10.1007/s10330-022-0582-2 · Cited by 1
Qu, F., Tong, J., Qian, W., & He, Q. (2026) · Oncology Reports · doi:10.3892/or.2026.9140 · Cited by 1
“Lipid peroxidation products not only disrupt DC membrane structure, but also block antigen presentation pathways, suppressing T‑cell activation and thereby weak‑ ening overall antitumor immunity (45,71).”
Think global but act local: Tuning the dendritic cell response in cancer
Bravo‐Blas, A., Pirillo, C., Shergold, A. L., Andrusaite, A. T., & Roberts, E. W. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106227 · Cited by 1
Cancer Cell–Intrinsic SSBP4 Enables Tumor Immune Evasion by Promoting Cholesterol Biosynthesis
Ou, P., Eres, I. E., Zhao, J., Han, C.-J., Oh, J., Kim, A., Dong, J., Zhou, H., Yamawaki, T., Li, C.-M., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-1312 · Cited by 1
Phospholipid Peroxidation in Health and Disease
Ouyang, S., Duan, W., Sun, W., Wu, Y., Li, Y.-F., Sun, J. Y., Lin, X., Li, Z., & He, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-39171-2_19 · Cited by 1
Lee, W., Kingstad-Bakke, B. A., Paulson, B. R., Larsen, A., Overmyer, K. A., Marinaik, C. B., Dulli, K., Toy, R., Vogel, G., Mueller, K. P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.08.083790 · Cited by 1
Computational Studies of Lipid Oxidation and Signaling
Mohammadyani, D. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Self-citationImmunoregulatory Myeloid Cells in the Tumor Microenvironment
Ginderachter, J. A. V. (2016) · SpringerBriefs in immunology · doi:10.1007/978-3-319-26821-7_5
Application of Antigen Cross-Presentation Research into Patient Care
(2017) · Frontiers research topics · doi:10.3389/978-2-88945-191-3
Molecular Mechanisms of Tumor Dendritic Cell Dysfunction in Cancer
Tang, M. (2016) · TSpace (University of Toronto)
Perez, V. M. (2019) · Lincoln (University of Nebraska)
Metabolic Requirements of NK Cell Responses to Viral Infection
Mah-Som, A. Y. (2020) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/2zc7-1134
Lamberti, M. J., Vera, R. E., Fernández-Zapico, M. E., & Vittar, N. B. R. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_159-1
Reactive Oxygen Species: Central Regulators of the Tumor Microenvironment
Lamberti, M. J., Vera, R. E., Fernández-Zapico, M. E., & Vittar, N. B. R. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_159
Faculty Opinions recommendation of Fatty acid transport protein 2 reprograms neutrophils in cancer.
den Eynde, B. J. V. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735565761.793560366
Diehl, J. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727294526.793538085
Immune Cell Metabolism and Function
Dixit, A. K., & Singh, M. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6226-3_1
de Blas, L. P. (2022) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/55107
Cholesterol Metabolism-Mediated Immune Regulation and Cancer ImmunotherapyPreprint
Zhang, J., Zhu, X., Han, L., Zhang, Z., Huang, X., Zhang, J., Li, J., Guo, C., & Yang, Q. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4760648
Zhu, L., Yang, F., Wang, L., Dong, L., Huang, Z., Wang, G., Chen, G., & Li, Q. (2021) · Figshare · doi:10.6084/m9.figshare.14059396
Zhu, L., Yang, F., Wang, L., Dong, L., Huang, Z., Wang, G., Chen, G., & Li, Q. (2021) · Figshare · doi:10.6084/m9.figshare.14059387
Zhu, L., Yang, F., Wang, L., Dong, L., Huang, Z., Wang, G., Chen, G., & Li, Q. (2021) · Figshare · doi:10.6084/m9.figshare.14059399
Zhu, L., Yang, F., Wang, L., Dong, L., Huang, Z., Wang, G., Chen, G., & Li, Q. (2021) · Figshare · doi:10.6084/m9.figshare.14059375
Dendritic Cells in the Tumor Microenvironment
Shurin, M. R., & Umansky, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00009-0
Sheng, X., Li, X., Zhang, Q., Ji, Q., & Wang, X. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107137
Metadata
- Authors
- Cao, W., Ramakrishnan, R., Tuyrin, V. A., Veglia, F., Condamine, T., Amoscato, A., Mohammadyani, D., Johnson, J. J., Min Zhang, L., Klein-Seetharaman, J., Celis, E., Kagan, V. E., & Gabrilovich, D. I.
- Affiliations
- Moffitt Cancer Center (US)
- University of Pittsburgh (US)
- The Wistar Institute (US)
- Molecular Core, H. Lee Moffitt Cancer Center and Research Institute , Tampa, FL 33612
- Division of Metabolic and Vascular Health, Medical School, University of Warwick , Coventry CV4 7AL,
- Corresponding author
- Gabrilovich, Dmitry I
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03
- Volume
- 192
- Issue
- 6
- Pages
- 2920-2931
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3998104
- OpenAlex
- W2149025737
- Cited by
- 302
- References
- 53
- Citations by year
- 2026: 28 · 2025: 36 · 2024: 27 · 2023: 24 · 2022: 40 · 2021: 48 · 2020: 29 · 2019: 21 · 2018: 13 · 2017: 21 · 2016: 7 · 2015: 5 · 2014: 3
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA165065, R01CA136828, R01CA165065, P30CA010815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- oxidized lipids, cross-presentation, dendritic cells, dendritic cell dysfunction, antitumor immunity, triglycerides, cholesterol esters, fatty acids, peptide-MHC class I complexes, tumor-derived factors, tumor immunology
- MeSH terms
- Acetylcysteine, Animals, Histocompatibility Antigens Class II, Cells, Cultured, Dendritic Cells, Flow Cytometry, Humans, Interferon-gamma, Lipids, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Neoplasms, Ovalbumin, Oxidation-Reduction, Peptide Fragments, Histocompatibility Antigens Class I, Cysteine Proteinase Inhibitors, Culture Media, Conditioned, Antigen Presentation, Microscopy, Confocal, Cross-Priming, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.